United States of America, ex rel. v. Sightpath Medical, Inc.

CourtDistrict Court, D. Minnesota
DecidedApril 2, 2019
Docket0:13-cv-03003
StatusUnknown

This text of United States of America, ex rel. v. Sightpath Medical, Inc. (United States of America, ex rel. v. Sightpath Medical, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States of America, ex rel. v. Sightpath Medical, Inc., (mnd 2019).

Opinion

UNITDEIDS TSRTIACTTE OSF D MISINTNREICSTO CTOAU RT

United States of America, ex rel., et al., Case No. 13-cv-3003 (WMW/DTS)

Plaintiffs,

v. ORDER

Cameron-Ehlen Group, Inc., et al.,

Defendants. ______________________________________________________________________

INTRODUCTION In this qui tam action under the False Claims Act, Defendants Cameron-Ehlen Group (d/b/a Precision Lens) and Paul Ehlen move to compel discovery responsive to several interrogatories and a document request served on the Government. Specifically, they seek the basis for allegations in the Complaint that doctors paid below fair market value for expensive trips arranged by Defendants, as well as the identification of specific false claims of which the Government is currently aware. Defendants also seek production of memoranda of interviews the Government conducted during its pre-suit investigation. Relatedly, Defendants argue that the Government, though asserting privilege in response to some of the discovery requests, has provided an inadequate privilege log that must be supplemented. Defendants are entitled to almost all that they seek. FACTS The present action began more than five years ago when, in November 2013, Relator Kipp Fesenmaier filed a qui tam action under seal and served the United States Attorney’s Office. Over an approximately four-year period, the Government sought—and received—eleven extensions of the deadline to intervene in the case. The Government eventually decided to intervene against select defendants, including Precision Lens and Paul Ehlen, in late 2017. The Government filed its Complaint, which became the sole operative complaint, in February 2018. Compl. in Intervention, Docket No. 105; Order, Feb. 26, 2018, Docket No. 114. Nearly a year before Fesenmaier filed his qui tam action, the Federal Bureau of Investigation began investigating Defendants’ business activities. Herrett Decl. ¶¶ 2-3, Docket No. 182. The FBI interviewed Precision Lens employees in 2013, coordinating at least minimally with the United States Attorney’s Office. Id. at ¶ 4; Beimers Decl. ¶ 2, Docket No. 103. By 2014, Assistant United States Attorneys with the Office’s civil division were coordinating regularly with the FBI on the investigation, including

interviews of Precision Lens employees and customers. Herrett Decl. ¶ 5; Beimers Decl. ¶ 3. ANALYSIS Defendants bring the present motion to compel, seeking more fulsome responses to three Interrogatories and a Request for Production of Documents. Federal Rule of Civil Procedure 26(b) provides that “[p]arties may obtain discovery regarding any nonprivileged matter that is relevant to any party’s claim or defense and proportional to the needs of the case.” The rule contemplates a liberal scope of discovery, though this Court “possess[es] considerable discretion in determining the

need for, and form of, discovery.” In re Nat’l Hockey League Players’ Concussion Injury Litig., 120 F. Supp. 3d 942, 949 (D. Minn. 2015). I. Basis for Allegations of Below Fair Market Value Transfers In its Complaint, the Government alleges specific instances of physicians who were remunerated by not paying the full fair market value for trips and other benefits provided by Defendants. E.g., Compl. ¶¶ 56, 64-65, 97, 102, 121, 127, 131, 139. Defendants seek the Government’s estimation of the fair market value regarding these specific allegations, and the basis of such estimations. Their original Interrogatory was considerably broader: INTERROGATORY NO. 2: Identify each alleged kickback, including but not limited to the alleged provider, the recipient, the date, the nature of the kickback. For each such instance, identify: a) The amount and form of payment by the alleged provider. b) The amount and form of payment by the alleged recipient. c) The estimated fair value. d) The basis for the valuation.

Huyser Aff. Ex. 3, at 4, Docket No. 175-1. Although the Government partially answered the Interrogatory, it objected to providing an estimation for the fair market value “because it places the burden on the United States when this is in fact Defendants’ burden, and Defendants are in a position at this point in discovery to know more about various details than the United States.”1 Id. at 4-5. Because the Government made specific allegations in the Complaint regarding fair market value, the factual basis for those allegations is presumptively discoverable. Factual contentions must either “have evidentiary support or, if specifically so identified, will likely have evidentiary support after reasonable opportunity for further investigation or discovery.” Fed. R. Civ. P. 11(b); see also Summit Recovery v. Credit Card Reseller, Civ. No. 08-5273 (DSD/JSM), 2009 WL 10678533, at *3 (D. Minn. Sept. 3, 2009) (noting that plaintiff must be “aware of the information sought by [the] discovery” because it was the factual basis for an allegation subject to Rule 11). That the Interrogatory is possibly a contention interrogatory does not, alone, alter that presumption of discoverability. Fed. R. Civ. P. 33(b). Although courts often allow parties to wait until the end of discovery to

1 The Government reiterated this position in a letter to Defendants’ counsel. Huyser Aff. Ex. 2, at 2. answer contention interrogatories, BB&T Corp. v. United States, 233 F.R.D. 447, 450 (M.D.N.C. 2006), the Government mentioned specific instances of below fair market value payments in its Complaint for which it must have had some basis. Defendants may discover the basis for these initial allegations at this stage of the litigation, even if it is not the full universe of facts that ultimately are offered in support of the allegation at trial. The Government’s remaining arguments on this issue are unpersuasive. It argues that Defendants bear the burden of proof on the question of fair market value, and further stresses that a payment need not be below fair market value to be a remuneration under the Anti-Kickback Statute. None of this is relevant to the question

currently before the Court. The Government made allegations in its Complaint for which it must have had some basis. That basis is discoverable at this stage of the litigation. The Government shall state its estimation for the fair market value of the specific allegations in the Complaint, as well as its basis for each of those estimations. If it does not have an estimation, the Government must still state the basis for its allegations. II. Identification of False Claims Defendants next seek a more exacting response to their first Interrogatory, which sought specification of the alleged false claims at issue in this case, but to which the Government objected:

INTERROGATORY NO. 1: Identify each false claim alleged to have been submitted to the United States Government, including but not limited to the date, amount, identity of the submitting entity, billing codes, facility, Surgical Supplies, and Complaint Physician associated with each claim. For each such instance, identify the breakdown of the facility fee and the physician fee.

ANSWER: . . . The United States further objects to this interrogatory in that discovery is ongoing and the United States is still learning about the conduct described therein. Finally, the United States objects to this iindteenrtriofigcaattoiorny oafs “ eita icsh o fvaelsrley cblraoimad.” 2a n .d . .u nduly burdensome in that it seeks

Huyser Aff. Ex. 3, at 3-4.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Upjohn Co. v. United States
449 U.S. 383 (Supreme Court, 1981)
In Re Grand Jury Subpoena Duces Tecum
112 F.3d 910 (Eighth Circuit, 1997)
In Re: Sealed Case
124 F.3d 230 (D.C. Circuit, 1997)
United States Ex Rel. Landis v. Tailwind Sports Corp.
303 F.R.D. 419 (District of Columbia, 2014)
Elnashar v. Speedway SuperAmerica, LLC
484 F.3d 1046 (Eighth Circuit, 2007)
United States v. All Assets Held at Bank Julius Baer & Co.
270 F. Supp. 3d 220 (District of Columbia, 2017)
United States v. Amerigroup Illinois, Inc.
230 F.R.D. 538 (N.D. Illinois, 2005)
BB & T Corp. v. United States
233 F.R.D. 447 (M.D. North Carolina, 2006)
Strauss v. Credit Lyonnais, S.A.
242 F.R.D. 199 (E.D. New York, 2007)
Steptoe & Johnson LLP v. UBS AG
250 F.R.D. 8 (District of Columbia, 2008)
Bartholomew v. Avalon Capital Group, Inc.
278 F.R.D. 441 (D. Minnesota, 2011)
In re Wirebound Boxes Antitrust Litigation
129 F.R.D. 534 (D. Minnesota, 1990)
Onwuka v. Federal Express Corp.
178 F.R.D. 508 (D. Minnesota, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
United States of America, ex rel. v. Sightpath Medical, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-of-america-ex-rel-v-sightpath-medical-inc-mnd-2019.